Pfizer plans filing as vaccine proves 95 per cent effective
by from on (#5AJAR)
Pfizer Inc. said a final analysis of clinical-trial data showed its COVID-19 vaccine was 95 per cent effective, paving the way for the company to apply for the first U.S. regulatory authorization for a coronavirus shot within days.